speb/financial-data huggingface dataset:
Stock screener scorecard for KROSS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 6.361432245420737 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 6.509980184014546%
Earnings yield: 2.291140274163134%
Return on net tangible assets: 5.092692897291774%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.8190666973415714%
Revenue growth: 20.849582364514816%
Rule of 40 score: 20.849582364514816
Market cap: 13297328128 (Large Cap ($10B-$200B))
P/E ratio: 0.18617308450973596
Debt to equity: 0.1097
Operating income: 3297053.8363713436
Net income: 2379186.0958033064
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for KROSS.NS (annual, report date 2026-03-31)
Altman Z-score: 7.309659580164913 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 16.50230070496362%
Earnings yield: 5.80786495392631%
Return on net tangible assets: -7.105978538579459%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.750887982358194%
Free cash flow margin: -10.758302498065214%
Revenue growth: -1.6334868915295997%
Rule of 40 score: -12.391789389594814
Market cap: 13297328128 (Large Cap ($10B-$200B))
P/E ratio: 0.18617308450973596
Debt to equity: 0.1097
Free cash flow (dilution adjusted): -7675392.1153030945
Operating income: 8357778.719796524
Net income: 5851526.0703688
Long score: 7 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for LFVN (quarterly, report date 2026-03-31)
Altman Z-score: 0.5450483485491435 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 5.089320918382821%
Earnings yield: 2.094768421977741%
Return on net tangible assets: 3.5882749326145555%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.9927663827154616%
Free cash flow margin: 7.486961295635465%
Revenue growth: -10.657865157057898%
Rule of 40 score: -3.170903861422433
Market cap: 82381320 (Micro Cap ($50M-$300M))
P/E ratio: 9.533333333333333
Debt to equity: 0.3061
Free cash flow (dilution adjusted): 3273000
Operating income: 1678000
Net income: 1362000
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for LTFOODS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.4873060816117234 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 4.430518460876284%
Earnings yield: 0.01682027501629914%
Return on net tangible assets: 7.287717733256825%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.7079557114062993%
Revenue growth: -1.5623591835893718%
Rule of 40 score: -1.5623591835893718
Market cap: 130428198912 (Large Cap ($10B-$200B))
P/E ratio: 0.21306765698652544
Debt to equity: 0.2849
Operating income: 21164211.530309454
Net income: 25820294.616362866
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for LTFOODS.NS (annual, report date 2026-03-31)
Altman Z-score: 3.6341307168003905 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 20.272600052361653%
Earnings yield: 0.07696406440629548%
Return on net tangible assets: 23.161517977152766%
Capitalized R&D asset: 838062.9348148005
ROCI (R&D adjusted): 16.84848743601507%
Rosenberg metric: 42.854969550505736
Free cash flow margin: 5.0329171930827155%
Revenue growth: 14.294697108553809%
Rule of 40 score: 19.327614301636522
Market cap: 130428198912 (Large Cap ($10B-$200B))
P/E ratio: 0.21306765698652544
Debt to equity: 0.2849
Free cash flow (dilution adjusted): 58380754.55701569
Operating income: 96840493.85332768
Net income: 117353168.71555744
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for PROTEAN.NS (annual, report date 2026-03-31)
Altman Z-score: 4.744840797767536 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 16.590610600360616%
Earnings yield: 0.03638034488715426%
Return on net tangible assets: 10.191101245053567%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.380119161758663%
Free cash flow margin: -0.019042846404409786%
Revenue growth: 7.587546269023374%
Rule of 40 score: 7.5685034226189645
Market cap: 24124925952 (Large Cap ($10B-$200B))
P/E ratio: 0.19060519626314754
Debt to equity: 0.0812
Free cash flow (dilution adjusted): -20135.65069944877
Operating income: 7898473.9296312
Net income: 10660237.388724037
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for PROTEAN.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.16313896754339 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 5.326892683035416%
Earnings yield: 0.011680956033135669%
Return on net tangible assets: 4.289161277868931%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.0485207505821115%
Revenue growth: 27.836841945683233%
Rule of 40 score: 27.836841945683233
Market cap: 24124925952 (Large Cap ($10B-$200B))
P/E ratio: 0.19060519626314754
Debt to equity: 0.0812
Operating income: 2536032.217041119
Net income: 3219584.5697329375
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for SURAKSHA.NS (annual, report date 2026-03-31)
Altman Z-score: 4.963802070971437 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 15.650297359245116%
Earnings yield: 0.04073707594368217%
Return on net tangible assets: 2.6827408448396484%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.006981287985854%
Free cash flow margin: 4.391456444794228%
Revenue growth: 11.62526015066906%
Rule of 40 score: 16.016716595463286
Market cap: 13173827584 (Large Cap ($10B-$200B))
P/E ratio: 0.38979631411204585
Debt to equity: 0.5353
Free cash flow (dilution adjusted): 1444648.1559983045
Operating income: 5766479.440440865
Net income: 3411095.803306486
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for SURAKSHA.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.1507885102091 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 3.8558190919102815%
Earnings yield: 0.010036537425882185%
Return on net tangible assets: 7.368452009587369%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.450949501502058%
Revenue growth: -0.30370437744411033%
Rule of 40 score: -0.30370437744411033
Market cap: 13173827584 (Large Cap ($10B-$200B))
P/E ratio: 0.38979631411204585
Debt to equity: 0.5353
Operating income: 1420707.9270877491
Net income: 665578.6350148368
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for TDG (quarterly, report date 2026-03-31)
Altman Z-score: 1.2045164485725512 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 15.184853524369963%
Earnings yield: 1.220018290806938%
Return on net tangible assets: -2.347224509965409%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.160420832971046%
Free cash flow margin: 1.4937106918238994%
Revenue growth: 11.334792122538294%
Rule of 40 score: 12.828502814362194
Market cap: 69173616640 (Large Cap ($10B-$200B))
P/E ratio: 36.1609984399376
Debt to equity: -3.4067489887162017
Free cash flow (dilution adjusted): 38000000
Operating income: 1187000000
Net income: 536000000
Long score: 6 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for VGNT (quarterly, report date 2026-03-31)
Altman Z-score: 1.0590407995762336 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 7.491021036428938%
Earnings yield: 3.5158892022165436%
Return on net tangible assets: -138.1818181818182%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.54290053151101%
Free cash flow margin: -1.7179023508137432%
Revenue growth: -5.110773240660289%
Rule of 40 score: -6.828675591474032
Market cap: 2952721152 (Mid Cap ($2B-$10B))
P/E ratio: 4.767964071856288
Debt to equity: 16.2867
Free cash flow (dilution adjusted): -47500000
Operating income: 182500000
Net income: 101250000
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for WAY (quarterly, report date 2026-03-31)
Altman Z-score: 1.4801407198325842 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 33.61335761788591%
Earnings yield: 1.4257214588229317%
Return on net tangible assets: -5.196345309004663%
Capitalized R&D asset: 34869390
ROCI (R&D adjusted): 1.4574476349717576%
Rosenberg metric: 0.32062634989200867
Free cash flow margin: 18.52335650611392%
Revenue growth: 3.405174969855504%
Rule of 40 score: 21.928531475969425
Market cap: 4317708288 (Mid Cap ($2B-$10B))
P/E ratio: 35.98507462686567
Debt to equity: 0.3775
Free cash flow (dilution adjusted): 58140000
Operating income: 80465000
Net income: 43283000
Long score: 9 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 6235.T (annual, report date 2025-12-31)
Altman Z-score: 3.351771700675816 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 6.615389950512748%
Earnings yield: 0.021517141803677045%
Return on net tangible assets: 5.530824694407776%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.03217636491948%
Free cash flow margin: 22.25411639711498%
Revenue growth: 4.87879240881222%
Rule of 40 score: 27.1329088059272
Market cap: 75852795534.16266 (Large Cap ($10B-$200B))
P/E ratio: 25.628879636607927
Debt to equity: 0.0938286481915784
Free cash flow (dilution adjusted): 48178057.668947
Operating income: 21319359.375998978
Net income: 18922453.807301324
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for ARAMI.PA (annual, report date 2025-09-30)
Altman Z-score: 5.213528288757136 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 18.055208406234698%
Earnings yield: 10.740941156010521%
Return on net tangible assets: 54.15188958413337%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.90252685786387%
Free cash flow margin: 3.016449271921261%
Revenue growth: 12.605806663098495%
Rule of 40 score: 15.622255935019755
Market cap: 474318842.54999995 (Small Cap ($300M-$2B))
P/E ratio: 23.87591072938689
Debt to equity: 0.5716674769081188
Free cash flow (dilution adjusted): 84447058.8235294
Operating income: 42491764.705882356
Net income: 23371764.70588235
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BELFA (annual, report date 2025-12-31)
Altman Z-score: 2.498256893143629 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 32.78121310238214%
Earnings yield: 3.33531782313294%
Return on net tangible assets: -1326.711575474292%
Capitalized R&D asset: 54090330
ROCI (R&D adjusted): 13.10482628400775%
Rosenberg metric: 2.6312219113033155
Free cash flow margin: 9.148944045125138%
Revenue growth: 26.302375502999297%
Rule of 40 score: 35.45131954812443
Market cap: 320906549.73 (Small Cap ($300M-$2B))
P/E ratio: 4.330079876536547
Debt to equity: 0.42685000597677925
Free cash flow (dilution adjusted): 61797000
Operating income: 107723000
Net income: 74111000
Long score: 12 | Short score: 3
Recommendation: Long
Stock screener scorecard for DICIND.NS (annual, report date 2025-12-31)
Altman Z-score: 4.0249096112669305 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 5.973922158732352%
Earnings yield: 0.06695433747472658%
Return on net tangible assets: 5.723765326951634%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.724069247460539%
Free cash flow margin: 3.5373574274386343%
Revenue growth: -3.2512950297156347%
Rule of 40 score: 0.2860623977229997
Market cap: 4428581033.190001 (Mid Cap ($2B-$10B))
P/E ratio: 25.485889260212012
Debt to equity: 0.009535329687762453
Free cash flow (dilution adjusted): 3500601.5372618916
Operating income: 2775504.0659463075
Net income: 1935680.0712933051
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for HHFA.DE (annual, report date 2025-12-31)
Altman Z-score: 1.2593609064518025 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 7.167176414432218%
Earnings yield: 5.7868561901732%
Return on net tangible assets: -21.421056245117448%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.653922609504822%
Free cash flow margin: -4.2026797799097935%
Revenue growth: 24.100465981783977%
Rule of 40 score: 19.897786201874183
Market cap: 1551819673.2 (Small Cap ($300M-$2B))
P/E ratio: 48.97647698279943
Debt to equity: 1.966260702545677
Free cash flow (dilution adjusted): -86831764.70588236
Operating income: 196788235.29411766
Net income: 37276470.5882353
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for LFVN (annual, report date 2025-06-30)
Altman Z-score: 4.688132155040669 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 32.16611733684904%
Earnings yield: 15.228891525450813%
Return on net tangible assets: 33.70740783812071%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 27.265818823897543%
Free cash flow margin: 2.1025685905570386%
Revenue growth: 14.171379468835553%
Rule of 40 score: 16.27394805939259
Market cap: 160725572.28 (Micro Cap ($50M-$300M))
P/E ratio: 16.392205229984704
Debt to equity: 0.33711497935971824
Free cash flow (dilution adjusted): 4805000
Operating income: 12199000
Net income: 9805000
Long score: 14 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ADTN (annual, report date 2025-12-31)
Altman Z-score: 0.8971475204112622 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 437895490
ROCI (R&D adjusted): -3.0717785904162116%
Rosenberg metric: 0.40996938471403155
Free cash flow margin: 4.653965143240447%
Revenue growth: 17.457842032252472%
Rule of 40 score: 22.11180717549292
Market cap: 703873489 (Small Cap ($300M-$2B))
Debt to equity: 0.471991185727659
Free cash flow (dilution adjusted): 50440000
Operating income: -15596000
Net income: -36243000
Long score: 6 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for ARCH.V (annual, report date 2025-09-30)
Altman Z-score: -519.6668618643013 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 2276695.6735411673
Rule of 40 score: 0
Market cap: 86954609.92 (Micro Cap ($50M-$300M))
Debt to equity: -0.6428019732394598
Free cash flow (dilution adjusted): -1139629.4964028778
Operating income: -893292.8057553958
Net income: -1117082.0143884893
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AVXL (annual, report date 2025-09-30)
Altman Z-score: 49.62327994407906 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -48.885304999525665%
Capitalized R&D asset: 80050070
ROCI (R&D adjusted): -31.344781332304134%
Rule of 40 score: 0
Market cap: 824778646.2 (Small Cap ($300M-$2B))
Debt to equity: 0
Free cash flow (dilution adjusted): -50593000
Operating income: -51371000
Net income: -46377000
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for BBD (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 17.750867732577962%
Capitalized R&D asset: 0
Free cash flow margin: -62.95034337912245%
Revenue growth: 26.140020528058173%
Rule of 40 score: -36.81032285106428
Market cap: 92546086507.39201 (Large Cap ($10B-$200B))
P/E ratio: 3.8682338367610694
Debt to equity: 2.5073471811435453
Free cash flow (dilution adjusted): -13533662043.79562
Net income: 4365809489.051095
Long score: 1 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for HOOD (annual, report date 2025-12-31)
Altman Z-score: 2.3088099050606035 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 22.755327821124958%
Capitalized R&D asset: 1710710000
ROCI (R&D adjusted): 19.419123548418256%
Rosenberg metric: 1.6919315403422983
Free cash flow margin: 28.593784931813097%
Revenue growth: 51.575737038292104%
Rule of 40 score: 80.1695219701052
Market cap: 89482989343.8 (Large Cap ($10B-$200B))
P/E ratio: 47.52150257238449
Debt to equity: 1.2704622445634357
Free cash flow (dilution adjusted): 1279000000
Operating income: 2094000000
Net income: 1883000000
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for IHS (annual, report date 2025-12-31)
Altman Z-score: -0.7468019761246769 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -33.56582388840453%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.822475123999638%
Free cash flow margin: 41.40328697850821%
Revenue growth: 11.987314711253951%
Rule of 40 score: 53.390601689762164
Market cap: 1858558588.4 (Small Cap ($300M-$2B))
P/E ratio: 12.94260855431755
Debt to equity: -39.08797327394198
Free cash flow (dilution adjusted): 885135135.135135
Operating income: 791486486.4864866
Net income: 194054054.05405405
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for LAR.TO (annual, report date 2025-12-31)
Altman Z-score: 0.2602341713559264 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -10.123977704849715%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.574359600647268%
Rule of 40 score: 0
Market cap: 723667932.5547446 (Small Cap ($300M-$2B))
Debt to equity: 0.30541794737144906
Free cash flow (dilution adjusted): -57265822.784810126
Operating income: -47412658.2278481
Net income: -95505063.29113923
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for LONA (annual, report date 2025-12-31)
Altman Z-score: -7.789507234352287 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -376.52752788772943%
Capitalized R&D asset: 95807640
ROCI (R&D adjusted): -55.06032604552822%
Rule of 40 score: 0
Market cap: 71108900.98 (Micro Cap ($50M-$300M))
Debt to equity: 0.028895286074127384
Free cash flow (dilution adjusted): -51831000
Operating income: -34178000
Net income: -105609000
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for MBLY (annual, report date 2025-12-31)
Altman Z-score: 8.076808913389849 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 641788382.2726523
ROCI (R&D adjusted): -1.751954633121428%
Rosenberg metric: 0.27387817441651124
Free cash flow margin: 12.988384371700107%
Revenue growth: 31.43475318077768%
Rule of 40 score: 44.42313755247778
Market cap: 8380128219.9336 (Mid Cap ($2B-$10B))
Debt to equity: 0
Free cash flow (dilution adjusted): 77358490.56603774
Operating income: -138364779.8742138
Net income: -123270440.25157233
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for NNOX (annual, report date 2025-12-31)
Altman Z-score: 11.915462642051985 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -84.88962638909842%
Capitalized R&D asset: 12128330.29634908
ROCI (R&D adjusted): -33.37792790284835%
Rosenberg metric: -0.2016177937996932
Free cash flow margin: -377.77436448813455%
Revenue growth: 32.46022707953246%
Rule of 40 score: -345.3141374086021
Market cap: 619725371.8319999 (Small Cap ($300M-$2B))
Debt to equity: 0.05618612773022643
Free cash flow (dilution adjusted): -15468553.459119495
Operating income: -19087735.8490566
Net income: -23590566.03773585
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for NXS.V (annual, report date 2026-01-31)
Altman Z-score: -83.51657863118768 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 4309.701492537313
Rule of 40 score: 0
Market cap: 9842101.249999998 (Nano Cap (< $50M))
Debt to equity: -1.7049286194732718
Free cash flow (dilution adjusted): -657821.4814814813
Operating income: -512638.5185185185
Net income: -1073377.037037037
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for OFIX (annual, report date 2025-12-31)
Altman Z-score: 1.3055046772273684 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -23.891344645658062%
Capitalized R&D asset: 141664040
ROCI (R&D adjusted): -10.946477789752151%
Rosenberg metric: 0.2733728935540377
Free cash flow margin: -3.6442372238274525%
Revenue growth: 2.8544411381741632%
Rule of 40 score: -0.7897960856532893
Market cap: 612792244.32 (Small Cap ($300M-$2B))
Debt to equity: 0.3964896219644163
Free cash flow (dilution adjusted): -29967000
Operating income: -82568000
Net income: -92192000
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for PCGH.L (annual, report date 2025-09-30)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.260293231572605%
Capitalized R&D asset: 0
Revenue growth: -141.2506652584503%
Rule of 40 score: -141.2506652584503
Market cap: 3625845 (Nano Cap (< $50M))
Debt to equity: 2.23159492088996e-06
Free cash flow (dilution adjusted): 14593243.243243244
Net income: -37909459.45945946
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for PEBK (annual, report date 2025-12-31)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.708168382998764%
Capitalized R&D asset: 0
Free cash flow margin: 26.567581369097216%
Revenue growth: 4.6021928591509695%
Rule of 40 score: 31.169774228248187
Market cap: 189758520.82 (Micro Cap ($50M-$300M))
P/E ratio: 9.569264791729701
Debt to equity: 0.12143102636235187
Free cash flow (dilution adjusted): 19770000
Net income: 19830000
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for RCFX.L (annual, report date 2025-08-31)
Altman Z-score: -0.306851028393917 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -114.11776327143998%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -58.79079213241717%
Free cash flow margin: -65.79053551295951%
Revenue growth: -35.09761033441608%
Rule of 40 score: -100.8881458473756
Market cap: 115131.2616 (Nano Cap (< $50M))
Debt to equity: 0.4021486986135283
Free cash flow (dilution adjusted): -3617985.135135135
Operating income: -1711897.2972972973
Net income: -1868975.6756756757
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for SGN.V (annual, report date 2025-12-31)
Altman Z-score: 16.754128682666998 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.11888282582456%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -30.63403953066591%
Rule of 40 score: 0
Market cap: 106037467.89999999 (Micro Cap ($50M-$300M))
P/E ratio: 34.14049254406511
Debt to equity: 0.026278219845659766
Free cash flow (dilution adjusted): -9321543.795620438
Operating income: -4469015.328467153
Net income: 2267091.2408759124
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for STC.TO (annual, report date 2025-06-30)
Altman Z-score: 1.8783661485325351 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 59401308.54508534
ROCI (R&D adjusted): 0.20655218107529885%
Rosenberg metric: -0.279998988442961
Free cash flow margin: 12.691176719111757%
Revenue growth: -4.2833341421199815%
Rule of 40 score: 8.407842576991776
Market cap: 280872987.59999996 (Micro Cap ($50M-$300M))
Debt to equity: 0.22072818112079312
Free cash flow (dilution adjusted): 21926277.372262772
Operating income: -927737.2262773722
Net income: -3656934.306569343
Long score: 6 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for SUPV (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.446231684958126%
Capitalized R&D asset: 0
Free cash flow margin: 35.04386316240256%
Revenue growth: -49.53014013757864%
Rule of 40 score: -14.486276975176082
Market cap: 1290153102320.421 (Mega Cap (>= $200B))
Debt to equity: 0.1898061564456059
Free cash flow (dilution adjusted): 274058458.5494906
Net income: -25884657.834363308
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for ZAIM.L (annual, report date 2024-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 0 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ZYUS.V (annual, report date 2025-12-31)
Altman Z-score: -64.28802287619027 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 3374132.2928895922
Rosenberg metric: -0.037486685689654554
Free cash flow margin: -2394.0740740740744%
Revenue growth: -12.112842769777084%
Rule of 40 score: -2406.1869168438516
Market cap: 56050080.8 (Micro Cap ($50M-$300M))
Debt to equity: -0.7545928030303031
Free cash flow (dilution adjusted): -7077372.262773722
Operating income: -10356934.306569342
Net income: -15862043.795620436
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 0042.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 215722384 (Micro Cap ($50M-$300M))
Debt to equity: -0.025247863433492248
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 0042.HK (annual, report date 2025-12-31)
Altman Z-score: -17.30292519741511 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -10.514710361210941%
Revenue growth: 9.437971594950897%
Rule of 40 score: -1.0767387662600445
Market cap: 215722384 (Micro Cap ($50M-$300M))
Debt to equity: -0.025247863433492248
Free cash flow (dilution adjusted): -2466000
Operating income: -1073000
Net income: -11813714.285714285
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 0137.HK (annual, report date 2025-12-31)
Altman Z-score: 1.0484419307994624 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 30.459979549538424%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.5145844040262231%
Free cash flow margin: 3.61547785638869%
Revenue growth: -1.1427833554261995%
Rule of 40 score: 2.4726945009624908
Market cap: 381808448 (Small Cap ($300M-$2B))
P/E ratio: 1.4567266495287061
Debt to equity: 0.4326
Free cash flow (dilution adjusted): 5708611.825192802
Operating income: 2638303.3419023138
Net income: 9317609.254498715
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0137.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 381808448 (Small Cap ($300M-$2B))
P/E ratio: 1.4567266495287061
Debt to equity: 0.4326
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0934.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 9422545920 (Mid Cap ($2B-$10B))
P/E ratio: 1.2978870148598658
Debt to equity: 0.0019
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0954.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 145667504 (Micro Cap ($50M-$300M))
Debt to equity: 1.0444
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0954.HK (annual, report date 2025-12-31)
Altman Z-score: 0.5003248014341574 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.953515668666394%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.170366761778828%
Free cash flow margin: 1.9187502805584238%
Revenue growth: -0.6841359032900093%
Rule of 40 score: 1.2346143772684144
Market cap: 145667504 (Micro Cap ($50M-$300M))
Debt to equity: 1.0444
Free cash flow (dilution adjusted): 1526571.4285714286
Operating income: -7379428.571428572
Net income: -9537571.42857143
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1080.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 224713200 (Micro Cap ($50M-$300M))
Debt to equity: 0.8069
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1080.HK (annual, report date 2025-12-31)
Altman Z-score: -0.6466765671820728 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.912926942485364%
Free cash flow margin: -1.4246582016112246%
Revenue growth: 65.22053094825864%
Rule of 40 score: 63.79587274664742
Market cap: 224713200 (Micro Cap ($50M-$300M))
Debt to equity: 0.8069
Free cash flow (dilution adjusted): -1838142.857142857
Operating income: -3281000
Net income: -2670571.4285714286
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 1771.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 96600000 (Micro Cap ($50M-$300M))
Debt to equity: 0.8739
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1771.HK (annual, report date 2025-12-31)
Altman Z-score: 1.4984765743799857 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -7.406876086716848%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -24.1195591804283%
Free cash flow margin: 0.23780647859619158%
Revenue growth: -11.024118423762278%
Rule of 40 score: -10.786311945166087
Market cap: 96600000 (Micro Cap ($50M-$300M))
Debt to equity: 0.8739
Free cash flow (dilution adjusted): 2495285.714285714
Operating income: -84249000
Net income: -35015571.428571425
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 2145.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 11131671552 (Large Cap ($10B-$200B))
P/E ratio: 2.86179916552547
Debt to equity: 0.21989999999999998
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2409.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1900000000 (Small Cap ($300M-$2B))
P/E ratio: 0.9594197576202717
Debt to equity: 2.0636
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 2453.HK (annual, report date 2025-12-31)
Altman Z-score: -0.07454093727557394 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -37.47124296466263%
Capitalized R&D asset: 8578111.836640326
ROCI (R&D adjusted): -4.815839491300868%
Rosenberg metric: 3.2249642673898697
Free cash flow margin: -56.52045346819678%
Revenue growth: 23.519641224589652%
Rule of 40 score: -33.00081224360713
Market cap: 564236672 (Small Cap ($300M-$2B))
Debt to equity: 1.5319
Free cash flow (dilution adjusted): -37135714.28571428
Operating income: -31209571.42857143
Net income: -36657571.428571425
Long score: 1 | Short score: 9
Recommendation: Short
Stock screener scorecard for 2453.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 564236672 (Small Cap ($300M-$2B))
Debt to equity: 1.5319
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 2696.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 30585808896 (Large Cap ($10B-$200B))
P/E ratio: 4.179214102093279
Debt to equity: 0.9081999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3395.HK (quarterly, report date 2026-03-31)
Altman Z-score: -19.83772298982497 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: 2.6366176571047224%
Revenue growth: 42.01354044733343%
Rule of 40 score: 44.650158104438155
Market cap: 226016064 (Micro Cap ($50M-$300M))
Debt to equity: -0.4945981694308923
Free cash flow (dilution adjusted): 57756.115107913676
Operating income: 85910.79136690649
Net income: -376497.8417266187
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 3822.HK (annual, report date 2026-03-31)
Altman Z-score: 1.9110698173836729 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 13.238778333672704%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.77981895861057%
Free cash flow margin: 15.680495694171833%
Revenue growth: -5.927604729881099%
Rule of 40 score: 9.752890964290735
Market cap: 76440000 (Micro Cap ($50M-$300M))
P/E ratio: 0.22133853541416565
Debt to equity: 0.34020000000000006
Free cash flow (dilution adjusted): 16701147.959183674
Operating income: 8795663.265306123
Net income: 7259566.326530612
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for 3822.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 76440000 (Micro Cap ($50M-$300M))
P/E ratio: 0.22133853541416565
Debt to equity: 0.34020000000000006
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3913.HK (annual, report date 2025-12-31)
Altman Z-score: 1.2139806615758655 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -14.285209559874481%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.882388033179112%
Free cash flow margin: 7.1249821690003365%
Revenue growth: -7.056283123606033%
Rule of 40 score: 0.06869904539430394
Market cap: 277542656 (Micro Cap ($50M-$300M))
Debt to equity: 0.1528
Free cash flow (dilution adjusted): 30495244.2159383
Operating income: 52181619.53727506
Net income: -40329562.98200514
Long score: 5 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 3913.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 277542656 (Micro Cap ($50M-$300M))
Debt to equity: 0.1528
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 4095.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 177551376384 (Large Cap ($10B-$200B))
P/E ratio: 0.07730830745348251
Debt to equity: 0.0011
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 5975.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 130538627072 (Large Cap ($10B-$200B))
P/E ratio: 0.039512845823240356
Debt to equity: 0.1838
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6040.T (quarterly, report date 2026-01-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 23802900480 (Large Cap ($10B-$200B))
P/E ratio: 0.11383078321192423
Debt to equity: 0.4844
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6666.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 9513513984 (Mid Cap ($2B-$10B))
P/E ratio: 1.4781491002570692
Debt to equity: 0.048600000000000004
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6666.HK (annual, report date 2025-12-31)
Altman Z-score: 3.8034507511641236 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 492.49969810949466%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 74.26781775660281%
Free cash flow margin: 8.629562315030908%
Revenue growth: 11.814351507230231%
Rule of 40 score: 20.443913822261138
Market cap: 9513513984 (Mid Cap ($2B-$10B))
P/E ratio: 1.4781491002570692
Debt to equity: 0.048600000000000004
Free cash flow (dilution adjusted): 168617000
Operating income: 228055142.85714287
Net income: 144163714.2857143
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 9337.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 4983888896 (Mid Cap ($2B-$10B))
P/E ratio: 0.07408851530129111
Debt to equity: 1.2333
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for AHF.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 12961332 (Nano Cap (< $50M))
Debt to equity: 0.0091
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AHF.AX (annual, report date 2025-06-30)
Altman Z-score: 1.8519676591764802 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -18.73382920055953%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -24.239727832772388%
Free cash flow margin: -48.32829482598701%
Revenue growth: 13.80869668084852%
Rule of 40 score: -34.51959814513849
Market cap: 12961332 (Nano Cap (< $50M))
Debt to equity: 0.0091
Free cash flow (dilution adjusted): -2264309.8039215687
Operating income: -3748795.424836601
Net income: -3404607.843137255
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for ARL.AX (quarterly, report date 2025-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 92279928 (Micro Cap ($50M-$300M))
Debt to equity: 0.2065
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ARL.AX (annual, report date 2025-06-30)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -4.317893902731417%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -11.130215549234105%
Rule of 40 score: 0
Market cap: 92279928 (Micro Cap ($50M-$300M))
Debt to equity: 0.2065
Free cash flow (dilution adjusted): -34897547.7124183
Operating income: -4930128.104575164
Net income: -2130246.405228758
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for ASAN (quarterly, report date 2026-04-30)
Altman Z-score: -2.080356586513564 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.147785840475391%
Capitalized R&D asset: 139477890
ROCI (R&D adjusted): -4.33620104248333%
Rosenberg metric: -0.012093468160699644
Free cash flow margin: -0.9615056437260782%
Revenue growth: -0.23106484409203676%
Rule of 40 score: -1.192570487818115
Market cap: 1628312320 (Small Cap ($300M-$2B))
Debt to equity: 1.8122
Free cash flow (dilution adjusted): -1972000
Operating income: -15240000
Net income: -14405000
Long score: 0 | Short score: 15
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AVM.AX (annual, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -50.93793758999454%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -32.98388579144669%
Rule of 40 score: 0
Market cap: 30643802 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -4552033.55704698
Operating income: -5027980.536912751
Net income: -4940398.657718121
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for AVM.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 30643802 (Nano Cap (< $50M))
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BELYS.BR (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 18978112 (Nano Cap (< $50M))
Debt to equity: 2.1182
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BELYS.BR (annual, report date 2025-12-31)
Altman Z-score: 0.28355131072118134 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.066022093498998%
Free cash flow margin: 7.15957501209587%
Revenue growth: 2.4027767258711243%
Rule of 40 score: 9.562351737966996
Market cap: 18978112 (Nano Cap (< $50M))
Debt to equity: 2.1182
Free cash flow (dilution adjusted): 21412941.17647059
Operating income: 16570588.235294119
Net income: -7791764.705882353
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for BEN.AX (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6067207680 (Mid Cap ($2B-$10B))
Debt to equity: 1.4257954784912252
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BLOE.L (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 15061144 (Nano Cap (< $50M))
Debt to equity: 0.0784
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BLOE.L (annual, report date 2025-12-31)
Altman Z-score: 1.2922799169043944 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.403898147774505%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.71660267962078%
Free cash flow margin: -24.071322436849922%
Revenue growth: -13.07436468726791%
Rule of 40 score: -37.14568712411783
Market cap: 15061144 (Nano Cap (< $50M))
Debt to equity: 0.0784
Free cash flow (dilution adjusted): -1970270.2702702703
Operating income: -3006756.756756757
Net income: -3402702.702702703
Long score: 2 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BNZ.AX (quarterly, report date 2026-01-31)
Altman Z-score: 135.50587387815526 (Safe Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -32.00061015543162%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -35.207979281682675%
Rule of 40 score: 0
Market cap: 1088374656 (Small Cap ($300M-$2B))
Debt to equity: 0.004
Free cash flow (dilution adjusted): -8976077.777777778
Operating income: -8026037.037037036
Net income: -6818074.074074074
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for CEPS.L (annual, report date 2025-12-31)
Altman Z-score: 1.0242691756500348 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.2406722016604985%
Free cash flow margin: 26.004656341734993%
Revenue growth: 5.045736205370316%
Rule of 40 score: 31.05039254710531
Market cap: 8505000 (Nano Cap (< $50M))
Debt to equity: 2.0103999999999997
Free cash flow (dilution adjusted): 3471621.621621622
Operating income: -302702.7027027027
Net income: -995945.9459459459
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for CEPS.L (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8505000 (Nano Cap (< $50M))
Debt to equity: 2.0103999999999997
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for CGTL (annual, report date 2025-09-30)
Altman Z-score: 153.1024898652157 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -74.02921914301824%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -72.96122132292243%
Free cash flow margin: -90.05672423723792%
Revenue growth: -40.6857277963841%
Rule of 40 score: -130.74245203362202
Market cap: 8249145 (Nano Cap (< $50M))
Debt to equity: 0.001
Free cash flow (dilution adjusted): -2448205.01285347
Operating income: -1691564.652956298
Net income: -1718476.7352185089
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for CGTL (quarterly, report date 2025-09-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 8249145 (Nano Cap (< $50M))
Debt to equity: 0.001
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CIPLA.NS (quarterly, report date 2026-06-30)
Piotroski F-score: 0 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Revenue growth: 8.982562680815446%
Rule of 40 score: 8.982562680815446
Market cap: 1139546521600 (Mega Cap (>= $200B))
P/E ratio: 0.37028590777091247
Debt to equity: 0.0178
Operating income: 93687097.79512607
Net income: 83241903.15434118
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CPEDU.NS (annual, report date 2026-03-31)
Altman Z-score: 23.42199918388387 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 31.01959032980081%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 74.00071001235317%
Free cash flow margin: 36.13201948903742%
Revenue growth: -6.489221705226661%
Rule of 40 score: 29.642797783810757
Market cap: 3392437504 (Mid Cap ($2B-$10B))
P/E ratio: 0.11886731438122282
Debt to equity: 0
Free cash flow (dilution adjusted): 1961636.2865621026
Operating income: 5986615.091140314
Net income: 2432884.6969054686
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for CPEDU.NS (quarterly, report date 2026-03-31)
Altman Z-score: 21.18413257696636 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 7.593489061193442%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.585339685891581%
Revenue growth: -30.70562861847491%
Rule of 40 score: -30.70562861847491
Market cap: 3392437504 (Mid Cap ($2B-$10B))
P/E ratio: 0.11886731438122282
Debt to equity: 0
Operating income: 1099046.2060194998
Net income: 592539.2115303094
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for CRBP (quarterly, report date 2026-03-31)
Altman Z-score: 0.5022441304190943 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -18.145984708173053%
Capitalized R&D asset: 39034820
ROCI (R&D adjusted): -14.62115428268605%
Rule of 40 score: 0
Market cap: 169899888 (Micro Cap ($50M-$300M))
Debt to equity: 0.0095
Free cash flow (dilution adjusted): -27493000
Operating income: -24304000
Net income: -22969000
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CSPI (quarterly, report date 2026-03-31)
Altman Z-score: 3.1509494081690637 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.9387164942720498%
Capitalized R&D asset: 1693160
ROCI (R&D adjusted): -1.6744571017186853%
Rosenberg metric: -0.30652680652680653
Free cash flow margin: -5.6020484636522605%
Revenue growth: 33.03423064140911%
Rule of 40 score: 27.43218217775685
Market cap: 80071184 (Micro Cap ($50M-$300M))
P/E ratio: 82.2152662310606
Debt to equity: 0.0461
Free cash flow (dilution adjusted): -897000
Operating income: -851000
Net income: 264000
Long score: 5 | Short score: 11
Recommendation: Short